WO1998000562A1 - Denaturation of double-stranded nucleic acid - Google Patents

Denaturation of double-stranded nucleic acid Download PDF

Info

Publication number
WO1998000562A1
WO1998000562A1 PCT/GB1997/001764 GB9701764W WO9800562A1 WO 1998000562 A1 WO1998000562 A1 WO 1998000562A1 GB 9701764 W GB9701764 W GB 9701764W WO 9800562 A1 WO9800562 A1 WO 9800562A1
Authority
WO
WIPO (PCT)
Prior art keywords
voltage
nucleic acid
electrodes
periods
denaturation
Prior art date
Application number
PCT/GB1997/001764
Other languages
French (fr)
Inventor
Duncan Ross Purvis
Susan Watson
Original Assignee
Scientific Generics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scientific Generics Limited filed Critical Scientific Generics Limited
Publication of WO1998000562A1 publication Critical patent/WO1998000562A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6825Nucleic acid detection involving sensors

Definitions

  • This invention relates to processes for the treatment of nucleic acid material in order to effect a complete or partial change from double-stranded form to single-stranded form and to processes of amplifying or detecting nucleic acids involving such denaturation processes.
  • Double-stranded DNA (deoxyribonucleic acid) and DNA/RNA (ribonucleic acid) and RNA/RNA complexes in the familiar double helical configuration are stable molecules that, in vitro, require aggressive conditions to separate the complementary strands of the nucleic acid.
  • Known methods that are commonly employed for strand separation require the use of high temperatures of at least 60°C and often 100°C or use an alkaline pH of 11 or higher.
  • Other methods include the use of helicase enzymes such as Rep protein of E.coli that can catalyse the unwinding of the DNA in an unknown way, or binding proteins such as 32 -protein of E.coli phage T4 that act to stabilise the single-stranded form of DNA.
  • the denatured single stranded DNA produced by the known processes of heat or alkali treatment is used commonly for hybridisation studies or is subjected to amplification cycles.
  • Such separation is a prerequisite of a number of protocols involving the in vitro manipulation of nucleic acids, one example of which is a reaction that produces multiple copies of target sequences of DNA and which employs a heat-stable polymerase enzyme (US Patent No. 4683202, K.B. Mullis et al) .
  • This development known as the polymerase chain reaction (PCR)
  • PCR polymerase chain reaction
  • strand separation is normally effected by heating the sample to approximately 95°C.
  • the removal of the need to heat the sample would provide a number of benefits. For example, it allows the design of compact and readily controllable apparatus, and the use of higher fidelity mesophyllic enzymes.
  • WO 92/04470 discloses a process whereby nucleic acid strands are separated by the application of an electric field. The advantages of the electrical method are discussed in greater detail, along with the method's application in amplification reactions such as PCR and ligase chain reaction. Forms of electrochemical cells for carrying out the reaction are described and also the use of "promoter" compounds that enhance the efficiency of denaturation.
  • a PCR reaction is conducted in which there are repeated denaturation operations conducted using the electro-chemical cell described with intervening amplification stages.
  • the denaturation stages are each conducted for a period of five minutes or longer and the total time for the PCR reaction is therefore very extended.
  • the conditions under which the PCR reaction was conducted in WO92/00470 differ from those of the conventional PCR process in that it was not found possible to use a conventional PCR buffer system. In order to obtain denaturation, it was necessary to conduct the process at a much lower ionic strength than would be consistent with such a buffer system. Excluding the promoter methyl viologen, the process was basically conducted in distilled water.
  • the present invention provides a process for denaturing double-stranded nucleic acid which comprises subjecting a solution containing said nucleic acid to a voltage applied between electrodes under conditions such as to convert at least a portion of said nucleic acid to a wholly or partially single-stranded form, wherein said voltage is applied such that there are, in any order, periods of application of voltage with a first polarity, periods of application of voltage with the opposite polarity to said first polarity and periods of substantially reduced applied voltage .
  • nucleic acid does not have to be in solution, but may be immobilised by one or both strands to a solid phase immersed in a liquid, e.g. a salt or buffer solution.
  • the invention also includes a process for amplifying a target sequence of nucleic acid comprising cycles of hybridisation, replication and denaturation of nucleic acid wherein said denaturation is conducted by subjecting a said nucleic acid to a voltage applied between electrodes such as to convert at least a portion of said nucleic acid to a wholly or partially single-stranded form, said voltage being applied such that there are, in any order, periods of application of voltage with a first polarity, periods of application of voltage with the opposite polarity to said first polarity and periods of substantially zero applied voltage.
  • the reduced voltage is preferably constant and should normally be less than one volt and preferably is less than 0.5V, e.g. less than 0.2V. Most preferably it is substantially zero.
  • the cycles are from 1 second to 5 minutes in length.
  • the periods during which the voltage is applied with a first polarity and the periods during which the voltage is applied with a second polarity are each somewhat shorter than the periods during which there is substantially no voltage applied.
  • the periods during which the voltage is applied with the first polarity or the opposite polarity are each independently from less than 0.1 seconds to 1 minute.
  • the periods of substantially zero applied voltage are each independently from 0.5 seconds to 3 minutes .
  • the electrodes approach to within 1.5 mm of one another or more closely, e.g. within 1 mm or more preferably 0.5 mm of one another. Ideally, the electrodes are adjusted to be spaced by as little as possible whilst ensuring that they do not contact one another to produce a short circuit .
  • the process is conducted at a voltage of 1 to 2 volts, e.g. 1.4 to 1.8 volts measured as a voltage difference between the electrodes.
  • a voltage of 1 to 2 volts e.g. 1.4 to 1.8 volts measured as a voltage difference between the electrodes.
  • one of the electrodes is in the nature of a rod, where the electrodes most closely approach one another, one or both of the electrodes is pointed.
  • Such an electrode may be provided with a single point or a plurality of points .
  • a further preferred electrode arrangement comprises a pair of parallel metal (e.g. platinum) plates. These are preferably spaced by up to 1.0 mm, e.g. from 0.3 to 0.5 mm .
  • a constant current regime it will generally be preferable to use a current of from 80 to 160 ⁇ A, e.g. about 100 to 125 ⁇ A. It should be borne in mind however that higher currents are desirable with increasing ionic strength of buffer used. The currents quoted are those for DNA in water.
  • a promoter compound such as methyl viologen to produce more rapid denaturation.
  • Other promoters are described in 093/15224, i.e. multivalent cations such as magnesium.
  • multi- valent cations which are effective and which can be used include lanthanum (La 3+ ) .
  • the cations used as the promoters may include inorganic cations complexed with inorganic or organic ligands, e.g. Pt(NH 3 ) 6 + and Cr(NH 3 ) 6 2+ .
  • the promoter may be any inorganic or organic molecule which increases the rate or extent of denaturation of the double helix. It should be soluble in the chosen reaction medium. It preferably does not affect or interfere with DNA or other materials such as enzymes or oligonucleotide probes which may be present in the solution. Alternatively, the promoter may be immobilised to or included in material from which the electrode is constructed.
  • the promoter may be a water-soluble compound of the bipyridyl series, especially a viologen such as methyl - viologen or a salt thereof. Whilst the mechanism of operation of such promoters is presently not known with certainty, it is believed that the positively charged viologen molecules interact between the negatively charged nucleic acid such as DNA and the negatively charged cathode to reduce electrostatic repulsion therebetween and hence to promote the approach of the DNA to the electrode surface where the electrical field is at its strongest. Accordingly, we prefer to employ as promoters compounds having spaced positively charged centres, e.g. bipolar positively charged compounds. Preferably the spacing between the positively charged centres is similar to that in viologens. Other suitable viologens include ethyl - viologen, isopropyl viologen and benzyl viologen.
  • the process may be conducted using a three electrode system of the kind described m WO92/04470 but generally it is preferred that the volume of solution employed according to this invention is small e.g. 1 ml or less, preferably very small e.g. 100 ⁇ l or less, e.g about 25 ⁇ l to 50 ⁇ l or less.
  • the volume of solution employed according to this invention is small e.g. 1 ml or less, preferably very small e.g. 100 ⁇ l or less, e.g about 25 ⁇ l to 50 ⁇ l or less.
  • the process may be carried out at ambient temperatures or if desired at temperatures up to adjacent the pre-melting temperature of the nucleic acid.
  • the process may be carried out at a pH of from 3 to 10, conveniently about 7. Generally, more rapid denaturation is obtained at lower pH . For some purposes therefore a pH somewhat below neutral e.g. about pH 5.5 may be preferred.
  • the nucleic acid may be dissolved in an aqueous solution containing a buffer whose nature and ionic strength are such as not to interfere with the strand separation process.
  • the solution contains a buffer at a concentration at least 10 mM, e.g. about 25 mM.
  • the solution may contain further salts such as magnesium chloride and sodium chloride.
  • the reaction is conducted in a buffer of the kind used in PCR or in LCR procedures .
  • the ionic strength of the solution is above 20 mM, e.g. 25 to 50 mM.
  • the denaturing process according to the invention may be incorporated as a step in a number of more complex processes, e.g. procedures involving the analysis and/or the amplification of nucleic acid. Some examples of such processes are described below.
  • Ampli ication procedures within the invention include both PCR and LCR.
  • a polymerase mediated replication procedure e.g. a polymerase chain reaction procedure
  • Once the primer is in position on a first of the target strands, rehybridisation of the target strands in the primer region will be prevented and the other target strand may be progressively displaced by extension of the primer or by further temporary weakening or separation processes.
  • Amplification processes according to the invention may be carried out over more than 1 cycle of the electrical profile, e.g. up to 5 to 10 cycles or more, e.g. up to 20 or 30 cycles.
  • the hybridisation step is preferably carried out using two primers which are complementary to different strands of the nucleic acid.
  • the denaturation to obtain the extension products as well as the original denaturing of the target nucleic acid is preferably carried out by applying to the solution of the nucleic acid the voltages from the electrodes.
  • the process may be a standard or classical PCR process for amplifying at least one specific nucleic acid sequence contained in a nucleic acid or a mixture of nucleic acids wherein each nucleic acid consists of two separate complementary strands, of equal or unequal length, which process comprises:
  • step (c) treating the single-stranded molecules generated from step (b) with the primers of step (a) under conditions such that a primer extension product is synthesised using each of the single strands produced in step (b) as a template.
  • the process may be any variant of the classical or standard PCR process, e.g. the so-called “inverted” or “inverse” PCR process or the "anchored” PCR process .
  • the invention therefore includes an amplification process as described above in which a primer is hybridised to a circular nucleic acid and is extended to form a duplex which is denatured by the denaturing process of the invention, the amplification process optionally being repeated through one or more additional cycles.
  • the process of the invention is applicable to the ligase chain reaction in a process for amplifying a target nucleic acid comprising the steps of :
  • the first and second said probes are primary probes, and the third and fourth of said probes are secondary nucleic acid probes,- ii) the first probe is a single strand capable of hybridising to a first segment of a primary strand of the target nucleic acid; iii) the second probe is a single strand capable of hybridising to a second segment of said primary strand of the target nucleic acid; iv) the 5' end of the first segment of said primary strand of the target is positioned relative to the
  • the third probe is capable of hybridising to the first probe; and iv) the fourth probe is capable of hybridising to the second probe; and
  • the electrochemical DNA amplification technique can be used analytically to detect and analyse a very small sample of DNA e.g a single copy gene in an animal cell or a single cell of a bacterium.
  • the temperature at which the process is carried out may be chosen to suit whichever enzyme is used. Thus where Taq is used as polymerase, a temperature of 55 to 68 °C is preferred. If Klenow polymerase is used, ambient temperature will be suitable. For Vent polymerase one preferably uses from 50 to 72 °C. It may be desirable to employ known protein stabilisation techniques to avoid electrical damage to the polymerase, especially where a mesophilic polymerase is used.
  • the invention includes a process for detecting the presence or absence of a predetermined nucleic acid sequence ln a sample which comprises: denaturing a sample double - stranded nucleic acid by means of said voltages applied to the sample in a solution; hybridising the denatured nucleic acid with an oligonucleotide probe for the sequence; and determining whether the said hybridisation has occurred.
  • the invented process has application in DNA and RNA hybridisation where a specific gene sequence is to be identified e.g. specific to a particular organism or specific to a particular hereditary disease of which sickle cell anaemia is an example.
  • a specific sequence e.g. specific to a particular organism or specific to a particular hereditary disease of which sickle cell anaemia is an example.
  • To detect a specific sequence it is first necessary to prepare a sample of DNA, preferably of purified DNA, means for which are known, which is in native double -stranded form. It is then necessary to convert the double-stranded DNA to single-stranded form before a hybridisation step with a labelled nucleotide probe which has a complementary sequence to the DNA sample can take place.
  • the denaturation process of the invention can be used for this purpose in a preferred manner by carrying out the following steps : - denaturing a sample of DNA by applying voltage cycles by means of electrodes to the sample DNA with optionally a promoter in solution or bound to or part of the structure of the electrode; hybridising the denatured DNA with a directly labelled or indirectly labelled nucleotide probe complementary to the sequence of interest; and determining whether the hybridisation has occurred, which determination may be by detecting the presence of the probe, the probe being directly radio- labelled, fluorescent labelled, chemiluminescent labelled or enzyme-labelled or being an indirectly labelled probe which carries biotin for example to which a labelled avidin or avidin type molecule can be bound later.
  • a typical DNA probe assay it is customary to immobilise the sample DNA to a membrane surface which may be composed of neutral or charged nylon or nitrocellulose.
  • the immobilisation is achieved by charge interactions or by baking the membrane containing DNA in an oven.
  • the sample DNA can be heated to high temperature to ensure conversion to single- stranded form before binding to the membrane or it can be treated with alkali once on the membrane to ensure conversion to the single-stranded form.
  • the disadvantages of such methods are : heating to high temperature to create single-stranded
  • DNA can cause damage to the sample DNA itself. - the use of alkali requires an additional step of neutralisation before hybridisation with the labelled probe can take place .
  • One improved method for carrying out DNA probe hybridisation assays is the so-called "sandwich” technique where a specific oligonucleotide is immobilised on a surface.
  • the surface having the specific oligonucleotide thereon is then hybridised with a solution containing the target DNA in a single-stranded form, after which a second labelled oligonucleotide is then added which also hybridises to the target DNA.
  • the surface is then washed to remove unbound labelled oligonucleotide, after which any label which has become bound to target DNA on the surface can be detected later .
  • This procedure can be simplified by using the denaturing process of the invention to denature the double-stranded DNA into the required single-stranded DNA.
  • the working electrode, counter-electrode and optionally a reference electrode and/or a promoter can be incorporated into a test surface or a well in which the DNA probe assay is to be carried out.
  • the DNA sample and oligonucleotide probes can then be added and the voltage applied to denature the DNA.
  • the resulting single - stranded DNA is hybridised with the specific oligonuclectide immobilised on the surface after which the remaining stages of a sandwich assay are carried out. All the above steps can take place without a need for high temperatures or addition of alkali reagents as in the conventional process.
  • Figure 1 is a cross-sectional view through a first example of a cell for use in accordance with the invention
  • Figure 2 is a cross-section through an alternative form of cell for use in the invention
  • Figure 3 shows an exploded perspective view of a third form of cell for use in the invention
  • Figure 4 is a side view of the cell of Figure 3;
  • Figure 5 is a plan view of the cell of Figure 3;
  • Figure 6 shows six voltage cycles for use with the cells of Figure 1 and Figure 2;
  • FIGS 7 to 15 show gels produced in the examples.
  • the cell illustrated in Figure 1 comprises a graphite block 10, containing a 4 mm diameter well 12 on its upper surface, constituting a first electrode.
  • a second electrode formed from a 2 mm diameter graphite rod 14 having a tapering end portion 16 is pressed into the well through an insulating collar of plastics material 18. The rod is adjusted down- wards in the well until it forms a short circuit and is then lifted back by as little as possible to open the circuit again.
  • the capacity for liquid for the cell is approximately
  • the rod electrode shown in Figure 1 is blunt ended, it provides a sharp edge between its flat end and its tapering frustoconical surface.
  • An optional alternative configuration is for the rod to be sharpened to a point. This may be achieved by using a conventional pencil sharpener.
  • the resulting electrode may be further smoothed using a blade or abrasive. Using such a pointed electrode, the capacity for liquid of the well is increased to 40 ⁇ l .
  • the cell shown in Figure 2 comprises a graphite block 20 fabricated from 6B pencil graphite containing a 3mm diameter well 22, which is 15mm deep, having at its upper end an enlarged diameter mouth portion 24.
  • a probe electrode 26 is formed from a 2B to 2H, e.g. HB pencil graphite and is 2mm in dia eter. It is supported in the well 22 by a sleeve 23 of PTFE in a base in which it is tightly received. A pair of 0- rings 30 received in grooves in the sleeve 28 provide a snug fit for the sleeve 28 in the mouth portion 24 of the block 20.
  • the precise height of the probe electrode in the well can be set by protruding by the desired extent fromt he lower end of the sleeve 28.
  • the end of the probe electrode is flat and not tapered .
  • a block containing the wells has a liftable lid with electrodes depending therefrom into the wells.
  • Each well may have a pair of electrodes on the lid in various possible electrode conformations such as parallel rods, parallel plates, optionally of mesh, or coaxial hollow cylinders, again optionally of mesh.
  • single electrodes may be provided on the lid for each well and the block containing the wells may be conductive and may serve as a common second electrode.
  • the block of wells may also contain respective electrodes for each well.
  • the lid may comprise a flat plate portion bearing the electrode or electrodes for each well and a separate backing member bearing electrical connections and circuitry which connects up the electrodes when the two parts are assembled.
  • a single electrical supply to the unit may be split by said circuitry and supplied in a controlled manner to the electrodes such that each electrode is controlled in voltage.
  • the plate portion carrying the electrode array may thereby be replaceable without replacement of the control circuitry and may be made disposable.
  • the plate portion and the backing member may be aligned with one another on assembly by locating pins and apertures and may similarly by aligned with the block containing the wells, which also may be disposable.
  • the cell shown in Figures 3 to 5 comprises a sandwich formed between a pair of opposed glass plates 30, 32 outside a pair of opposed platinum foil electrodes 34, 36 which lie either side of a spacer sheet 38 of a silicone elastomer (silasticTM) .
  • Each electrode is provided with a connecting tag 42, 44 by which electrical connection is made to it .
  • a chamber 40 is formed in the silastic'" sheet.
  • the chamber consists of a circular cut-out of diameter approximately 10 mm and a lead-in channel extending to the edge of the sheet.
  • the silastic'" sheet is approximately 400 ⁇ m in thickness.
  • two similar cavities 40 may be provided.
  • the provision of two cavities in the silasticTM sheet enables the conduct of two reactions according to the invention, or one such reaction with a control, simultaneously.
  • illustrated electrochemical cell comprises two opposing planar platinum electrodes.
  • the electrodes are separated by a sheet of deformable insulating material (in this instance a silicone elastomer) which forms a seal against liquid loss, and which is cut to form the electrode chamber.
  • the electrodes are backed by flat plates, and the whole is clamped together between aluminium blocks
  • Voltage cycle No. 2 is the first half cycle of cycle No. 1. This will provide amplification. Use of the second half cycle instead by itself does not appear to provide amplification although it does contribute to the overall good performance of cycle No. 1.
  • Voltage cycle No. 4 comprises periods of positive voltage in which the electrode 14 is made positive with respect to the well for a time a seconds followed by periods of zero voltage of duration c seconds followed by periods of negative voltage of duration b seconds. A further period of zero voltage of c seconds duration ends the cycle which is then repeated. The well is kept at earth in all the illustrated cycles.
  • voltage cycle No. 5 the first of the zero voltage periods is omitted and one goes directly from the positive voltage of a seconds duration to the negative voltage of b seconds duration and this is followed by a period of c seconds at zero voltage.
  • voltage cycle No. 6 a further period of b seconds of negative voltage is interposed between the period of c seconds of zero voltage and the start of the next cycle.
  • the order in which the periods of positive, zero and negative voltage occur and the number of times they occur in each cycle is largely immaterial provided that all three periods do occur, but there is a preference for starting with a positive voltage.
  • Preferred values for a and b in the illustrated voltage cycles 4 to 6 are from 5 to 20 seconds.
  • Preferred values for c in each cycle are from 30 to 120 seconds. The invention will be further illustrated by the following examples.
  • Example 1 The conditions of Example 1 were varied to the extent described below.
  • the agarose gel shown in Figure 7 illustrates amplification of a 500 bp amplicon with varying exposures to the electric field and annealing and extension times.
  • the lanes in Figure 7 are as follows :- M Lambda Hind III marker.
  • Each lane represents a different carbon well electrode.
  • the arrow marks the level at which the amplicon runs on the gel .
  • Lanes 1 and 2 show significant amplification compared to the controls, non specific amplification, probably of contaminants, has also occurred.
  • Example 1 The conditions of Example 1 were varied to the extent described below.
  • Figure 8 is an agarose gel showing the results.
  • the lanes are as follows :-
  • Control no electrical pulses, held on ice.
  • OH Control no electrical pules, incubated at 55°C. 1-2 10 cycles, 1.6 Volts for 15 seconds positive, 15 seconds negative polarity followed by 2 minutes annealing and extension. The amplicon runs at the level marked by the arrow.
  • Example 1 The conditions of Example 1 were varied to the extent described below.
  • Figure 9 is an agarose gel showing the results.
  • the lanes are as follows :-
  • Example 1 The conditions of Example 1 were varied to the extent described below.
  • Figure 10 is an agarose gel showing the results.
  • the lanes are as follows :-
  • Example 1 The conditions of Example 1 were varied to the extent described below.
  • Figure 11 is an agarose gel showing the results.
  • the lanes are as follows :-
  • Control no electrical pulses, held on ice.
  • OH Control no electrical pules, incubated at 55°C.
  • Vent buffer consists of 20 mM TrisHCl, 10 mM KC1, 10 mM(NH 4 ) 2 S0 4 and 0.1% Triton.
  • lanes 1-3 show the results obtained with different electrodes (all according to Figure 2) and lane 4 shows a thermal control.
  • the amplicon is marked by the arrow.
  • Example 7 shows how fine tuning of the conditions can improve the amplification obtained as is true also when using conventional thermal PCR.
  • Example 7 is repeated using different strengths of buffer, but with the concentration of MgS0 4 maintained constant at 4.5 mM.
  • the lanes in Figure 13 are as follows :- Lanes 1-3 1 x buffer
  • the following reaction mixture was subjected to electrical PCR in the cell shown in Figures 3 to 5 using the voltage profile shown as No. 7 in Figure 6.
  • a voltage of 0.5 - 0.6 5V was applied during both the positive and negative voltage periods. Twenty cycles of the voltage profile were used.
  • Table 1 illustrates the results of a Dig assay, which detects biotinylated amplicons of the desired sequence. The strongest signals were produced from the amplicons which gave bands in gels of highest intensities. In some cases, the biotin test readings were approximately 50% of those from the thermal control product.
  • Electrode cleaned using Brasso metal polish and a cotton bud Before the polish dries wash with detergent and rinse under the hot tap till the Pt surface shows hydrobobicity, rinse well with dH 2 0. Flick residual water off and allow to dry. 2. The electrodes are further cleaned by an electrochemical method. Sweeping between + and -2.4V at a ramp rate of 0.02V/s. This is performed for at least 1 hr. A faster ramp rate can also be used of O.lV/s,

Abstract

Double-stranded nucleic acid is denatured by subjecting a solution thereof to a voltage applied between electrodes spaced by no more than 1.5 mm in a time not previously achievable in electrochemical denaturation. PCR is practised isothermally by periodic application of voltage to produce denaturation. Electrochemical cells and kits for use in the process are provided.

Description

DENATURATION OF DOUBLE-STRANDED NUCLEIC ACID
This invention relates to processes for the treatment of nucleic acid material in order to effect a complete or partial change from double-stranded form to single-stranded form and to processes of amplifying or detecting nucleic acids involving such denaturation processes.
Double-stranded DNA (deoxyribonucleic acid) and DNA/RNA (ribonucleic acid) and RNA/RNA complexes in the familiar double helical configuration are stable molecules that, in vitro, require aggressive conditions to separate the complementary strands of the nucleic acid. Known methods that are commonly employed for strand separation require the use of high temperatures of at least 60°C and often 100°C or use an alkaline pH of 11 or higher. Other methods include the use of helicase enzymes such as Rep protein of E.coli that can catalyse the unwinding of the DNA in an unknown way, or binding proteins such as 32 -protein of E.coli phage T4 that act to stabilise the single-stranded form of DNA. The denatured single stranded DNA produced by the known processes of heat or alkali treatment is used commonly for hybridisation studies or is subjected to amplification cycles.
Such separation is a prerequisite of a number of protocols involving the in vitro manipulation of nucleic acids, one example of which is a reaction that produces multiple copies of target sequences of DNA and which employs a heat-stable polymerase enzyme (US Patent No. 4683202, K.B. Mullis et al) . This development, known as the polymerase chain reaction (PCR) , is of significant commercial importance and strand separation is normally effected by heating the sample to approximately 95°C. The removal of the need to heat the sample would provide a number of benefits. For example, it allows the design of compact and readily controllable apparatus, and the use of higher fidelity mesophyllic enzymes. WO 92/04470 discloses a process whereby nucleic acid strands are separated by the application of an electric field. The advantages of the electrical method are discussed in greater detail, along with the method's application in amplification reactions such as PCR and ligase chain reaction. Forms of electrochemical cells for carrying out the reaction are described and also the use of "promoter" compounds that enhance the efficiency of denaturation.
Prior to WO92/04470, a number of other workers had described denaturation of DNA in electrochemical cells. However, in none of these cases was single- stranded product left free in solution in useful quantities. Rather, DNA appears to have become irreversibly bound to the surface of the electrode, in which condition it is not available for further participation in processes such as PCR. In the method of electrical denaturation described in WO92/04470, single strands accumulate in solution and their utility and integrity is confirmed by subsequently performing PCR.
In WO92/04470 electrical denaturation of DNA was carried out using an electrode comprising a central rod of glassy carbon encased in a teflon sleeve except at its end. The working electrode was of platinum mesh lying against the teflon sleeve. A calomel reference electrode was used, situated in a side chamber which was connected to the main cell by a capillary tube (see Stanley CJ. et al , J. Immunol. Meth. [1988] , 112, 153-161) . Using this apparatus the most rapid denaturation was achieved in 15 minutes with the working electrode at a potential of -IV with respect to the reference. The presence of NaCl in the reaction delayed denaturation. In W092/04470, a PCR reaction is conducted in which there are repeated denaturation operations conducted using the electro-chemical cell described with intervening amplification stages. The denaturation stages are each conducted for a period of five minutes or longer and the total time for the PCR reaction is therefore very extended. Furthermore, the conditions under which the PCR reaction was conducted in WO92/00470 differ from those of the conventional PCR process in that it was not found possible to use a conventional PCR buffer system. In order to obtain denaturation, it was necessary to conduct the process at a much lower ionic strength than would be consistent with such a buffer system. Excluding the promoter methyl viologen, the process was basically conducted in distilled water.
In 095/25177 we showed it is possible to conduct a denaturation electrochemically considerably faster than is disclosed in O92/04470 and to conduct an amplification procedure much faster than is disclosed there.
Although the spacing between the two working electrodes in O92/04470 is not explicitly stated, it was in fact several millimetres . An improved method is described in 095/25177 in which a solution containing said nucleic acid is subjected to a voltage applied between electrodes which approach to within 1.5 mm of one another in said solution. This results in a substantial increase in the rate of denaturation such that 095/25177 contains examples in which complete denaturation of DNA is achieved within 1 to 2 minutes in comparison with denaturation times of at 25 minutes using the electrode set up of WO92/04470.
It is indicated in 095/25177 that rather than simply turning the electrical field on and off when conducting PCR using the apparatus described there, one may optionally reverse the field. In W095/25177, this reversal of the field is seen as being merely an equivalent to turning the field off. It has now been found surprisingly that the process of electrochemical denaturation and PCR processes based upon it are greatly further accelerated if one employs not only periods during which the electric field is reduced substantially to zero but also further periods during which the field is reversed. The combination of all three field conditions in any order in a cyclic manner in a PCR process leads to substantially more rapid amplification and produces conditions favourable for the use of mesophyllic polymerases .
Accordingly, the present invention provides a process for denaturing double-stranded nucleic acid which comprises subjecting a solution containing said nucleic acid to a voltage applied between electrodes under conditions such as to convert at least a portion of said nucleic acid to a wholly or partially single-stranded form, wherein said voltage is applied such that there are, in any order, periods of application of voltage with a first polarity, periods of application of voltage with the opposite polarity to said first polarity and periods of substantially reduced applied voltage .
It will be understood that the nucleic acid does not have to be in solution, but may be immobilised by one or both strands to a solid phase immersed in a liquid, e.g. a salt or buffer solution.
The invention also includes a process for amplifying a target sequence of nucleic acid comprising cycles of hybridisation, replication and denaturation of nucleic acid wherein said denaturation is conducted by subjecting a said nucleic acid to a voltage applied between electrodes such as to convert at least a portion of said nucleic acid to a wholly or partially single-stranded form, said voltage being applied such that there are, in any order, periods of application of voltage with a first polarity, periods of application of voltage with the opposite polarity to said first polarity and periods of substantially zero applied voltage.
The reduced voltage is preferably constant and should normally be less than one volt and preferably is less than 0.5V, e.g. less than 0.2V. Most preferably it is substantially zero.
Preferably, the cycles are from 1 second to 5 minutes in length. Preferably the periods during which the voltage is applied with a first polarity and the periods during which the voltage is applied with a second polarity are each somewhat shorter than the periods during which there is substantially no voltage applied. Suitably, the periods during which the voltage is applied with the first polarity or the opposite polarity are each independently from less than 0.1 seconds to 1 minute. Preferably, the periods of substantially zero applied voltage are each independently from 0.5 seconds to 3 minutes .
Preferably, there is a long positive voltage application, e.g. 5 to 30 seconds, followed by a short negative voltage application 0.1 to 10 seconds, followed by a longer period of substantially zero volts. The apparatus employed is preferably as described in 095/25177 or as illustrated herein. Preferably, the electrodes approach to within 1.5 mm of one another or more closely, e.g. within 1 mm or more preferably 0.5 mm of one another. Ideally, the electrodes are adjusted to be spaced by as little as possible whilst ensuring that they do not contact one another to produce a short circuit .
It is preferred to apply a voltage difference of from 0.5 to 3 volts between the electrodes. Voltage differences above 3 volts seem to inhibit denaturation or produce degradation according to the nature of the electrode set up, although the mechanism involved here is presently unknown.
Preferably, the process is conducted at a voltage of 1 to 2 volts, e.g. 1.4 to 1.8 volts measured as a voltage difference between the electrodes. Preferably, if one of the electrodes is in the nature of a rod, where the electrodes most closely approach one another, one or both of the electrodes is pointed. Such an electrode may be provided with a single point or a plurality of points . There appears to be some inter-relationship between the ideal voltage applied and the shape of the electrode and it may be that there is a preferred or ideal field gradient at the point of the electrode which can be achieved by adjustment of the voltage to suit the sharpness of the part of the electrode at which the denaturation takes place. Optionally, one can conduct the denaturation using a constant current supply rather than a regulated voltage and this may serve to compensate for variations in the geometrical set-up of the % electrodes between different denaturation operations. However, a further preferred electrode arrangement comprises a pair of parallel metal (e.g. platinum) plates. These are preferably spaced by up to 1.0 mm, e.g. from 0.3 to 0.5 mm . Where a constant current regime is employed, it will generally be preferable to use a current of from 80 to 160 μA, e.g. about 100 to 125 μA. It should be borne in mind however that higher currents are desirable with increasing ionic strength of buffer used. The currents quoted are those for DNA in water.
As described in WO92/04470, one may employ a promoter compound such as methyl viologen to produce more rapid denaturation. Other promoters are described in 093/15224, i.e. multivalent cations such as magnesium. Other multi- valent cations which are effective and which can be used include lanthanum (La3+) . The cations used as the promoters may include inorganic cations complexed with inorganic or organic ligands, e.g. Pt(NH3)6 + and Cr(NH3)6 2+.
The promoter may be any inorganic or organic molecule which increases the rate or extent of denaturation of the double helix. It should be soluble in the chosen reaction medium. It preferably does not affect or interfere with DNA or other materials such as enzymes or oligonucleotide probes which may be present in the solution. Alternatively, the promoter may be immobilised to or included in material from which the electrode is constructed.
The promoter may be a water-soluble compound of the bipyridyl series, especially a viologen such as methyl - viologen or a salt thereof. Whilst the mechanism of operation of such promoters is presently not known with certainty, it is believed that the positively charged viologen molecules interact between the negatively charged nucleic acid such as DNA and the negatively charged cathode to reduce electrostatic repulsion therebetween and hence to promote the approach of the DNA to the electrode surface where the electrical field is at its strongest. Accordingly, we prefer to employ as promoters compounds having spaced positively charged centres, e.g. bipolar positively charged compounds. Preferably the spacing between the positively charged centres is similar to that in viologens. Other suitable viologens include ethyl - viologen, isopropyl viologen and benzyl viologen.
Optionally, the process may be conducted using a three electrode system of the kind described m WO92/04470 but generally it is preferred that the volume of solution employed according to this invention is small e.g. 1 ml or less, preferably very small e.g. 100 μl or less, e.g about 25 μl to 50 μl or less. When using very small reaction volumes of this kind, it will generally not be practical to use a three electrode system.
The process may be carried out at ambient temperatures or if desired at temperatures up to adjacent the pre-melting temperature of the nucleic acid. The process may be carried out at a pH of from 3 to 10, conveniently about 7. Generally, more rapid denaturation is obtained at lower pH . For some purposes therefore a pH somewhat below neutral e.g. about pH 5.5 may be preferred. The nucleic acid may be dissolved in an aqueous solution containing a buffer whose nature and ionic strength are such as not to interfere with the strand separation process.
Preferably, the solution contains a buffer at a concentration at least 10 mM, e.g. about 25 mM. Optionally, the solution may contain further salts such as magnesium chloride and sodium chloride. Preferably, the reaction is conducted in a buffer of the kind used in PCR or in LCR procedures .
Preferably therefore the ionic strength of the solution is above 20 mM, e.g. 25 to 50 mM.
The denaturing process according to the invention may be incorporated as a step in a number of more complex processes, e.g. procedures involving the analysis and/or the amplification of nucleic acid. Some examples of such processes are described below.
We have found that by virtue of the superior cell design described in W095/25177 and herein, in combination with the voltage regime described herein it is possible to achieve denaturation much more quickly than before.
Ampli ication procedures within the invention include both PCR and LCR. In such a polymerase mediated replication procedure, e.g. a polymerase chain reaction procedure, it may not be necessary in all cases to carry out denaturation to the point of producing wholly single-stranded molecules of nucleic acid. It may be sufficient to produce a sufficient local and/or temporary weakening or separation of the double helix in the primer hybridisation site to allow the primer to bind to its target. Once the primer is in position on a first of the target strands, rehybridisation of the target strands in the primer region will be prevented and the other target strand may be progressively displaced by extension of the primer or by further temporary weakening or separation processes.
Amplification processes according to the invention may be carried out over more than 1 cycle of the electrical profile, e.g. up to 5 to 10 cycles or more, e.g. up to 20 or 30 cycles. In the amplification process the hybridisation step is preferably carried out using two primers which are complementary to different strands of the nucleic acid.
The denaturation to obtain the extension products as well as the original denaturing of the target nucleic acid is preferably carried out by applying to the solution of the nucleic acid the voltages from the electrodes.
The process may be a standard or classical PCR process for amplifying at least one specific nucleic acid sequence contained in a nucleic acid or a mixture of nucleic acids wherein each nucleic acid consists of two separate complementary strands, of equal or unequal length, which process comprises:
(a) treating the strands with two oligonucleotide primers, for each different specific sequence being applied, under conditions such that for each different sequence being amplified an extension product of each primer is synthesised which is complementary to each nucleic acid strand, wherein said primers are selected so as to be substantially complementary to different strands of each specific sequence such that the extension product synthesised from one primer, when it is separated from its complement, can serve as a template for synthesis of the extension product of the other primer;
(b) separating the primer extension products from the templates on which they were synthesised to produce single-stranded molecules by applying the voltages from the electrode to the reaction mixture; and
(c) treating the single-stranded molecules generated from step (b) with the primers of step (a) under conditions such that a primer extension product is synthesised using each of the single strands produced in step (b) as a template.
Alternatively, the process may be any variant of the classical or standard PCR process, e.g. the so-called "inverted" or "inverse" PCR process or the "anchored" PCR process .
The invention therefore includes an amplification process as described above in which a primer is hybridised to a circular nucleic acid and is extended to form a duplex which is denatured by the denaturing process of the invention, the amplification process optionally being repeated through one or more additional cycles.
The process of the invention is applicable to the ligase chain reaction in a process for amplifying a target nucleic acid comprising the steps of :
(a) providing nucleic acid of a sample as single-stranded nucleic acid;
(b) providing in the sample at least four nucleic acid probes, wherein: i) the first and second said probes are primary probes, and the third and fourth of said probes are secondary nucleic acid probes,- ii) the first probe is a single strand capable of hybridising to a first segment of a primary strand of the target nucleic acid; iii) the second probe is a single strand capable of hybridising to a second segment of said primary strand of the target nucleic acid; iv) the 5' end of the first segment of said primary strand of the target is positioned relative to the
3 ' end of the second segment of said primary strand of the target to enable joining of the 3' end of the first probe to the 5' end of the second probe, when said probes are hybridised to said primary strand of said target nucleic acid;
v) the third probe is capable of hybridising to the first probe; and iv) the fourth probe is capable of hybridising to the second probe; and
(c) repeatedly or continuously: i) hybridising said probes with nucleic acid in said sample; ii) ligating hybridised probes to form reorganised fused probe sequences; and iii) denaturing DNA in said sample by applying said voltages as described to the reaction mixture.
The electrochemical DNA amplification technique can be used analytically to detect and analyse a very small sample of DNA e.g a single copy gene in an animal cell or a single cell of a bacterium.
The temperature at which the process is carried out may be chosen to suit whichever enzyme is used. Thus where Taq is used as polymerase, a temperature of 55 to 68 °C is preferred. If Klenow polymerase is used, ambient temperature will be suitable. For Vent polymerase one preferably uses from 50 to 72 °C. It may be desirable to employ known protein stabilisation techniques to avoid electrical damage to the polymerase, especially where a mesophilic polymerase is used. The invention includes a process for detecting the presence or absence of a predetermined nucleic acid sequence ln a sample which comprises: denaturing a sample double - stranded nucleic acid by means of said voltages applied to the sample in a solution; hybridising the denatured nucleic acid with an oligonucleotide probe for the sequence; and determining whether the said hybridisation has occurred.
Thus, the invented process has application in DNA and RNA hybridisation where a specific gene sequence is to be identified e.g. specific to a particular organism or specific to a particular hereditary disease of which sickle cell anaemia is an example. To detect a specific sequence it is first necessary to prepare a sample of DNA, preferably of purified DNA, means for which are known, which is in native double -stranded form. It is then necessary to convert the double-stranded DNA to single-stranded form before a hybridisation step with a labelled nucleotide probe which has a complementary sequence to the DNA sample can take place.
The denaturation process of the invention can be used for this purpose in a preferred manner by carrying out the following steps : - denaturing a sample of DNA by applying voltage cycles by means of electrodes to the sample DNA with optionally a promoter in solution or bound to or part of the structure of the electrode; hybridising the denatured DNA with a directly labelled or indirectly labelled nucleotide probe complementary to the sequence of interest; and determining whether the hybridisation has occurred, which determination may be by detecting the presence of the probe, the probe being directly radio- labelled, fluorescent labelled, chemiluminescent labelled or enzyme-labelled or being an indirectly labelled probe which carries biotin for example to which a labelled avidin or avidin type molecule can be bound later. In a typical DNA probe assay it is customary to immobilise the sample DNA to a membrane surface which may be composed of neutral or charged nylon or nitrocellulose. The immobilisation is achieved by charge interactions or by baking the membrane containing DNA in an oven. The sample DNA can be heated to high temperature to ensure conversion to single- stranded form before binding to the membrane or it can be treated with alkali once on the membrane to ensure conversion to the single-stranded form. The disadvantages of such methods are : heating to high temperature to create single-stranded
DNA can cause damage to the sample DNA itself. - the use of alkali requires an additional step of neutralisation before hybridisation with the labelled probe can take place .
One improved method for carrying out DNA probe hybridisation assays is the so-called "sandwich" technique where a specific oligonucleotide is immobilised on a surface. The surface having the specific oligonucleotide thereon is then hybridised with a solution containing the target DNA in a single-stranded form, after which a second labelled oligonucleotide is then added which also hybridises to the target DNA. The surface is then washed to remove unbound labelled oligonucleotide, after which any label which has become bound to target DNA on the surface can be detected later .
This procedure can be simplified by using the denaturing process of the invention to denature the double-stranded DNA into the required single-stranded DNA. The working electrode, counter-electrode and optionally a reference electrode and/or a promoter can be incorporated into a test surface or a well in which the DNA probe assay is to be carried out. The DNA sample and oligonucleotide probes can then be added and the voltage applied to denature the DNA. The resulting single - stranded DNA is hybridised with the specific oligonuclectide immobilised on the surface after which the remaining stages of a sandwich assay are carried out. All the above steps can take place without a need for high temperatures or addition of alkali reagents as in the conventional process. The invention will be further described and illustrated with reference to the accompanying drawings in which:
Figure 1 is a cross-sectional view through a first example of a cell for use in accordance with the invention; Figure 2 is a cross-section through an alternative form of cell for use in the invention;
Figure 3 shows an exploded perspective view of a third form of cell for use in the invention;
Figure 4 is a side view of the cell of Figure 3; Figure 5 is a plan view of the cell of Figure 3;
Figure 6 shows six voltage cycles for use with the cells of Figure 1 and Figure 2; and
Figures 7 to 15 show gels produced in the examples.
The cell illustrated in Figure 1 comprises a graphite block 10, containing a 4 mm diameter well 12 on its upper surface, constituting a first electrode. A second electrode formed from a 2 mm diameter graphite rod 14 having a tapering end portion 16 is pressed into the well through an insulating collar of plastics material 18. The rod is adjusted down- wards in the well until it forms a short circuit and is then lifted back by as little as possible to open the circuit again. The capacity for liquid for the cell is approximately
25 μl.
Although the rod electrode shown in Figure 1 is blunt ended, it provides a sharp edge between its flat end and its tapering frustoconical surface. An optional alternative configuration is for the rod to be sharpened to a point. This may be achieved by using a conventional pencil sharpener. The resulting electrode may be further smoothed using a blade or abrasive. Using such a pointed electrode, the capacity for liquid of the well is increased to 40 μl .
The cell shown in Figure 2 comprises a graphite block 20 fabricated from 6B pencil graphite containing a 3mm diameter well 22, which is 15mm deep, having at its upper end an enlarged diameter mouth portion 24. A probe electrode 26 is formed from a 2B to 2H, e.g. HB pencil graphite and is 2mm in dia eter. It is supported in the well 22 by a sleeve 23 of PTFE in a base in which it is tightly received. A pair of 0- rings 30 received in grooves in the sleeve 28 provide a snug fit for the sleeve 28 in the mouth portion 24 of the block 20. The precise height of the probe electrode in the well can be set by protruding by the desired extent fromt he lower end of the sleeve 28. The end of the probe electrode is flat and not tapered .
Multiple processes according to the invention may be carried out simultaneously in apparatus containing a multiplicity of sample receiving wells each provided with a respective electrode pair, one electrode in each case optionally being the well itself. In a preferred form for such apparatus a block containing the wells has a liftable lid with electrodes depending therefrom into the wells. Each well may have a pair of electrodes on the lid in various possible electrode conformations such as parallel rods, parallel plates, optionally of mesh, or coaxial hollow cylinders, again optionally of mesh. Alternatively, single electrodes may be provided on the lid for each well and the block containing the wells may be conductive and may serve as a common second electrode. The block of wells may also contain respective electrodes for each well.
The lid may comprise a flat plate portion bearing the electrode or electrodes for each well and a separate backing member bearing electrical connections and circuitry which connects up the electrodes when the two parts are assembled. A single electrical supply to the unit may be split by said circuitry and supplied in a controlled manner to the electrodes such that each electrode is controlled in voltage. The plate portion carrying the electrode array may thereby be replaceable without replacement of the control circuitry and may be made disposable. The plate portion and the backing member may be aligned with one another on assembly by locating pins and apertures and may similarly by aligned with the block containing the wells, which also may be disposable. The cell shown in Figures 3 to 5 comprises a sandwich formed between a pair of opposed glass plates 30, 32 outside a pair of opposed platinum foil electrodes 34, 36 which lie either side of a spacer sheet 38 of a silicone elastomer (silastic™) . Each electrode is provided with a connecting tag 42, 44 by which electrical connection is made to it . A chamber 40 is formed in the silastic'" sheet. The chamber consists of a circular cut-out of diameter approximately 10 mm and a lead-in channel extending to the edge of the sheet. The silastic'" sheet is approximately 400 μm in thickness.
Optionally two similar cavities 40 (or more) may be provided. The provision of two cavities in the silastic™ sheet enables the conduct of two reactions according to the invention, or one such reaction with a control, simultaneously.
Thus, it can be seen that illustrated electrochemical cell comprises two opposing planar platinum electrodes. The electrodes are separated by a sheet of deformable insulating material (in this instance a silicone elastomer) which forms a seal against liquid loss, and which is cut to form the electrode chamber. The electrodes are backed by flat plates, and the whole is clamped together between aluminium blocks
(not shown) compressing the elastomer sheet from a free state thickness of about 500 μm. The potential difference between the electrodes and the polarity reversal pattern over time are set on a PC, which controls a power supply. The electrode assemblies are maintained at the operating temperature
(suitably 55°C) by standing them on a heating block of appropriate temperature. Voltage cycle No. 1 in Figure 6 consists of a seconds at a positive voltage (suitably 1.6V as shown) , b seconds at a negative voltage, c seconds at substantially zero voltage, b' seconds at the negative voltage, a' seconds at the positive voltage and c seconds at substantially zero voltage, repeated in cycles. Time values found suitable include: a = b' = 25s, b = a' = 5s, c = 25 to 45s.
Voltage cycle No. 2 is the first half cycle of cycle No. 1. This will provide amplification. Use of the second half cycle instead by itself does not appear to provide amplification although it does contribute to the overall good performance of cycle No. 1.
Cycle No. 3 comprises six repeats of: a seconds of positive voltage and b seconds of negative voltage, followed by b' seconds of negative voltage and c seconds of substantially zero voltage in which suitable time values are a = 5s, b = 0.2s, b' = 5s, c = 45s.
In each case illustrated 12 cycles of the illustrated profile are generally sufficient in an amplification.
Voltage cycle No. 4 comprises periods of positive voltage in which the electrode 14 is made positive with respect to the well for a time a seconds followed by periods of zero voltage of duration c seconds followed by periods of negative voltage of duration b seconds. A further period of zero voltage of c seconds duration ends the cycle which is then repeated. The well is kept at earth in all the illustrated cycles. In voltage cycle No. 5, the first of the zero voltage periods is omitted and one goes directly from the positive voltage of a seconds duration to the negative voltage of b seconds duration and this is followed by a period of c seconds at zero voltage. In voltage cycle No. 6, a further period of b seconds of negative voltage is interposed between the period of c seconds of zero voltage and the start of the next cycle. Generally it may be said that the order in which the periods of positive, zero and negative voltage occur and the number of times they occur in each cycle is largely immaterial provided that all three periods do occur, but there is a preference for starting with a positive voltage.
In voltage cycle No. 7, there is a positive voltage period a followed by a similar duration negative voltage period b. There is then a brief zero voltage period c followed by a return to negative voltage for b seconds and then to positive voltage for a seconds. This cycle is succeeded by a much longer zero voltage period c' befor being repeated. Strictly speaking, it is not necessary that the application of the voltages be cyclic so that periods of positive, zero and negative voltage occur in some repeated order. If these voltages are applied in random sequence a satisfactory result may be obtained but this is unnecessarily complicated in practice and it is preferable that the positive voltage periods occur at fixed intervals.
Preferred values for a and b in the illustrated voltage cycles 4 to 6 are from 5 to 20 seconds. Preferred values for c in each cycle are from 30 to 120 seconds. The invention will be further illustrated by the following examples.
Example 1
Electrical PCR using Vent Polymerase. Amplification of a 500 bp amplicon is carried out in the probe/well electrode system shown in Figure 1 or Figure 2 at 1.6 volts. The following mixture is placed in the well. Electric PCR mix: i.e. 20 μl vent buffer 2 μl MgS04
32 μl primer #1 and #2
20 μl 1/20 dilution of 500 bp amplicon 1 μl Vent polymerase 85 μl dH20 Amplification was conducted using 10, 30 second pulses of 1.6 volts (positive and negative for alternate pulses) , at 55 °C with 2 minutes annealing and extension being allowed at zero volts after each positive and each negative pulse. Amplification was found to occur.
Example 2
The conditions of Example 1 were varied to the extent described below.
The agarose gel shown in Figure 7 illustrates amplification of a 500 bp amplicon with varying exposures to the electric field and annealing and extension times. The lanes in Figure 7 are as follows :- M Lambda Hind III marker.
0 Control: no electrical pulses, held on ice. OH Control: no electrical pulses, incubated at 55°C.
1-3 10 cycles of 1.6 volts positive for 30 seconds, 1.6 V negative for 30 seconds, and 2 minutes zero voltage. Each lane represents a different carbon well electrode. The arrow marks the level at which the amplicon runs on the gel .
Lanes 1 and 2 show significant amplification compared to the controls, non specific amplification, probably of contaminants, has also occurred.
Example 3
The conditions of Example 1 were varied to the extent described below.
Figure 8 is an agarose gel showing the results. The lanes are as follows :-
M Lambda Hind III marker.
0 Control: no electrical pulses, held on ice. OH Control: no electrical pules, incubated at 55°C. 1-2 10 cycles, 1.6 Volts for 15 seconds positive, 15 seconds negative polarity followed by 2 minutes annealing and extension. The amplicon runs at the level marked by the arrow.
Example 4
The conditions of Example 1 were varied to the extent described below.
Figure 9 is an agarose gel showing the results. The lanes are as follows :-
O Control: no electrical pulses, held on ice. OH Control: no electrical pules, incubated at
55°C. 1-6 15 seconds positive, 15 seconds negative polarity at 1.6 volts for 10 cycles with 1 minute annealing and extension time. Using six different carbon well electrodes M Lambda Hind III marker. Amplification occurred visibly in all cases (seen at the level marked by the arrow) , controls are not visible due to the dilution factor. The annealing and extension time has been reduced by one minute, whilst still allowing amplification to occur. This results in a total time of 15 minutes for electrical PCR.
Example 5
Confirming the importance of reversing the polarity.
To confirm that reversing the polarity is important for amplification, electrical PCR was tested at 1.6 volts, using 10, 30 second positive pulses with 2 minutes annealing and extension time, using the standard ePCR reaction mix described in Example 1.
The conditions of Example 1 were varied to the extent described below. Figure 10 is an agarose gel showing the results. The lanes are as follows :-
M Lambda Hind III marker.
0 Control: no electrical pulses, held on ice.
OH Control: no electrical pules, incubated at
55°C. 1-6 6 different cuvette well electrodes. No amplification occurred under these conditions. These data confirm that reversing the polarity is highly beneficial for ePCR amplification.
Example 6
Electrical amplification of 2 ng/50 μl 500 bp amplicon.
The conditions of Example 1 were varied to the extent described below. Figure 11 is an agarose gel showing the results. The lanes are as follows :-
M Lambda Hind III marker.
0 Control: no electrical pulses, held on ice. OH Control: no electrical pules, incubated at 55°C.
1-3 1.6 volt pulses of 10 seconds positive, 10 seconds negative followed by 1 minute annealing and extension (a = repeated) using three different cuvette well electrodes. 4-6 As above, but the voltage was lowered to 1.4 volts (a = repeated) . Amplification has again occurred. The amount of amplified product is variable, probably due to variation between the electrodes used.
Example 7
Using the cell of Figure 2 and the electrical profile shown at (1) in Figure 3, electrical PCR was carried out using the following mixture: -21-
Mix μl
H20 234 lOx Vent Buffer 80
125μM dNTP's 64
20μM primer 2 4
20μM primer 3 4 lOOmM MgS04 2 lOOng/ml Template 10
2U/μl Vent 1
Vent buffer consists of 20 mM TrisHCl, 10 mM KC1, 10 mM(NH4)2S04 and 0.1% Triton.
In Figure 12, lanes 1-3 show the results obtained with different electrodes (all according to Figure 2) and lane 4 shows a thermal control. The amplicon is marked by the arrow.
Example 8
This example shows how fine tuning of the conditions can improve the amplification obtained as is true also when using conventional thermal PCR. Example 7 is repeated using different strengths of buffer, but with the concentration of MgS04 maintained constant at 4.5 mM. The lanes in Figure 13 are as follows :- Lanes 1-3 1 x buffer
4-6 2 x buffer
7-9 3 x buffer
10-11 3.5 x buffer
12-13 4 x buffer 14-15 5 x buffer
The best results are obtained at 2 to 3 x buffer. Ξxample 9
The following reaction mixture was subjected to electrical PCR in the cell shown in Figures 3 to 5 using the voltage profile shown as No. 7 in Figure 6. The voltage periods were a = 10 seconds, b = 10 seconds, c = 1 second, c' = 50 seconds. A voltage of 0.5 - 0.6 5V was applied during both the positive and negative voltage periods. Twenty cycles of the voltage profile were used.
Reaction Mix lOmM Ches buffer, pH 7.5 0.1% Triton X-100 and 3mM MgS04, 200 μM of each dNTP,
0.2 μM if each primer to give a 375bp fragment, 1 ng pUC linearised plasmid as starting material (lxl0"9g) ,
0.5U Vent polymerase,
Thermal profile (in control runs): 25 cycles of: 94°C-45 sec 54°C-20 sec 72°C-25 sec followed by 1 cycle of: 72°C-2 min.
55°C constant on hot block
Electrical amplification was achieved at a potential of 0.5V (Figure 14). This voltage may not cause full denaturation, but there is clearly a sufficient degree of strand separation occurring to allow primer binding and extension. Also, it was found that consistency was improved by increasing the concentration of Ches to lOmM, which although not optimal for denaturation may have the effect of stabilising the reaction components. The identity of the electrical amplification bands generated was confirmed by the following tests:
• initial visual screening on an ethidium bromide-stained gel, • extraction of the sample with phenol-chloroform-ISA and precipitation from the aqueous phase with ethanol and re-running on a gel,
• detection of the biotinylated amplicon in the Dig-based assay • the non-appearance of the band (in an agarose gel) following treatment of the electrically-generated amplicon with DNase (Figure 15) .
Table 1 illustrates the results of a Dig assay, which detects biotinylated amplicons of the desired sequence. The strongest signals were produced from the amplicons which gave bands in gels of highest intensities. In some cases, the biotin test readings were approximately 50% of those from the thermal control product.
TABLE 1
Biotin-Dig Assay Results
375 bp band Absorbance on gel at 405nm
Electrical amplification + 0.40 product , unpurified
Electrical amplification + 0.50 product, purified by phenol extraction and ethanol precipitation
Electrical amplification mix, - 0.05 no electric field cycling
Thermal PCR product, purified + 1.20
Thermal PCR negative control - 0.06 (no polymerase)
Test reagent blank - 0.05
The data presented here demonstrate using electrical denaturation to achieve isothermal amplification of a 375bp sequence from 2686bp linearised pUC DNA.
Denaturation has been found to be sensitive to the condition of the electrode surfaces, and electrical amplification even more so. Recommended electrode preparation techniques include:
1. Electrode cleaned using Brasso metal polish and a cotton bud. Before the polish dries wash with detergent and rinse under the hot tap till the Pt surface shows hydrobobicity, rinse well with dH20. Flick residual water off and allow to dry. 2. The electrodes are further cleaned by an electrochemical method. Sweeping between + and -2.4V at a ramp rate of 0.02V/s. This is performed for at least 1 hr. A faster ramp rate can also be used of O.lV/s,
3. Check that electrical denaturation of 0.3μg/ml linear pUC18 in 5mM CHES pH7.6 occurs at 0.8V. This is a requirement before ePCR can be attempted. The denaturation priming generally requires a few cycles at 1.8V in the presence of pUC then denaturation cycles from 1.8V down to 0.8V in 0.2V steps.
Generally a suitable PCR reaction mix is : -
1/8 x Thermopol Buffer 5mM CHES pH7.6
0.075% Triton X-100
0.6μM Primer).2
0.4μM Primer|tl
200μM dNTP's -9ng Lin pUC18
3mM MgS04
Without wishing to be bound by any theory, we believe it is probable that reversing the polarity during each cycle may be forcing the DNA away from the electrode surface back into solution where it mixes with the other PCR components allowing annealing and extension to proceed.
Whilst the invention has been described above in terms of the preferred embodiments illustrated by the examples, many modifica ions and variations thereof are possible within the scope of the invention.

Claims

1. A process for denaturing double-stranded nucleic acid which comprises subjecting a said nucleic acid to a voltage applied between electrodes under conditions such as to convert at least a portion of said nucleic acid to a wholly or partially single stranded form, wherein said voltage is applied such that there are, in any order, periods of application of voltage with a first polarity, periods of application of voltage with the opposite polarity to said first polarity and periods of substantially reduced applied voltage .
2. A process as claimed in Claim 1, wherein said cycles are from 1 second to 5 minutes in length.
3. A process as claimed in Claim 2, wherein the periods during which said voltage is applied with a first polarity and said periods during which said voltage is applied with a second polarity are each independently of from 0.5 seconds to 1 minute .
4. A process as claimed in Claim 2 or Claim 3, wherein the periods during which said voltage is substantially zero are each independently from 0.5 seconds to 3 minutes .
5. A process as claimed in any preceding claim, wherein said electrodes approach to within 1.5mm of one another in said solution.
6. A process as claimed in Claim 5, wherein the electrodes approach to within 1 mm of one another in said solution.
7. A process as claimed in Claim 6, wherein the electrodes approach to within 0.5 mm of one another in said solution.
8. A process as claimed in any preceding claim, wherein a voltage of from 0.5 to 3 volts is applied between said electrodes .
9. A process as claimed in Claim 8, wherein a voltage of from 1.5 to 2.5 volts is applied between said electrodes.
10. A process as claimed in any preceding claim, wherein the solution contains a promoter which assists said denaturation.
11. A process as claimed in Claim 10, wherein said promoter is methyl viologen or a salt thereof, or is a multivalent inorganic cation.
12. A process as claimed in Claim 11, wherein said promoter is magnesium or lanthanum ions.
13. A process as claimed in any preceding claim, wherein where the electrodes most closely approach one another, one or both of the electrodes is pointed.
14. A process of amplifying a target sequence of nucleic acid comprising hybridisation, replication and denaturation of nucleic acid wherein said denaturation is conducted by subjecting a solution containing said nucleic acid to a voltage applied between electrodes under conditions such as to convert at least a portion of said nucleic acid to a wholly or partially single stranded form in the solution said voltage being applied such that there are, in any order, periods of application of voltage with a first polarity, periods of application of voltage with the opposite polarity to said first polarity and periods of substantially zero applied voltage.
15. A process of amplifying a target sequence of nucleic acid as claimed in claim 14, wherein said electrodes approach to within 1.5mm of one another in said solution.
16. A process as claimed in Claim 14 or Claim 15, wherein said cycles are from 1 second to 5 minutes in length.
17. A process as claimed in Claim 14, wherein the periods during which said voltage is applied with a first polarity and said periods during which said voltage is applied with a second plurality are each independently of rom 0.5 seconds to 1 minute.
18. A process as claimed in Claim 16 or Claim 17, wherein the periods during which said voltage is substantially zero are each independently from 0.5 seconds to 3 minutes.
19. A process of amplifying a target sequence as claimed in any one of claims 14 to 18, which is a PCR or LCR amplification.
PCT/GB1997/001764 1996-07-02 1997-06-30 Denaturation of double-stranded nucleic acid WO1998000562A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9613980.3A GB9613980D0 (en) 1996-07-02 1996-07-02 Denaturation of double-stranded nucleic acid
GB9613980.3 1996-07-02

Publications (1)

Publication Number Publication Date
WO1998000562A1 true WO1998000562A1 (en) 1998-01-08

Family

ID=10796298

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/001764 WO1998000562A1 (en) 1996-07-02 1997-06-30 Denaturation of double-stranded nucleic acid

Country Status (2)

Country Link
GB (1) GB9613980D0 (en)
WO (1) WO1998000562A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044100A1 (en) * 1997-04-02 1998-10-08 Scientific Generics Limited Disassociation of interacting molecules
WO2001055708A2 (en) * 2000-01-27 2001-08-02 Abbott Laboratories Method of processing a sample containing at least one biological element
US6806053B1 (en) 1999-06-09 2004-10-19 Ljl Biosystems, Inc. Cell-signaling assays
US8101032B1 (en) 2007-05-18 2012-01-24 University Of Central Florida Research Foundation, Inc. Ethanol based gel fuel for a hybrid rocket engine
EP2766945A1 (en) * 2011-10-12 2014-08-20 Areva Electrode for electrochemical cell and method of manufacturing such an electrode
US9862984B2 (en) 2006-04-21 2018-01-09 Nanobiosym, Inc. Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
US10933417B2 (en) 2013-03-15 2021-03-02 Nanobiosym, Inc. Systems and methods for mobile device analysis of nucleic acids and proteins

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004470A1 (en) * 1990-09-12 1992-03-19 Scientific Generics Limited Electrochemical denaturation of double-stranded nucleic acid
WO1993015224A1 (en) * 1992-01-23 1993-08-05 Scientific Generics Limited Electrochemical treatment of nucleic acid containing solutions
WO1995025177A1 (en) * 1994-03-15 1995-09-21 Scientific Generics Limited Electrochemical denaturation of double-stranded nucleic acid
WO1997008293A1 (en) * 1995-08-25 1997-03-06 Scientific Generics Limited Release of intracellular material

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004470A1 (en) * 1990-09-12 1992-03-19 Scientific Generics Limited Electrochemical denaturation of double-stranded nucleic acid
WO1993015224A1 (en) * 1992-01-23 1993-08-05 Scientific Generics Limited Electrochemical treatment of nucleic acid containing solutions
WO1995025177A1 (en) * 1994-03-15 1995-09-21 Scientific Generics Limited Electrochemical denaturation of double-stranded nucleic acid
WO1997008293A1 (en) * 1995-08-25 1997-03-06 Scientific Generics Limited Release of intracellular material

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
C.J. STANLEY ET AL.: "Amperometric enzyme-amplified immunoassays", J. IMMUNOL. METHODS, vol. 112, no. 2, 1988, ELSEVIER, AMSTERDAM NL, pages 153 - 161, XP002043865 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044100A1 (en) * 1997-04-02 1998-10-08 Scientific Generics Limited Disassociation of interacting molecules
US6333157B1 (en) 1997-04-02 2001-12-25 Affymetrix, Inc. Disassociation of interacting molecules
US6806053B1 (en) 1999-06-09 2004-10-19 Ljl Biosystems, Inc. Cell-signaling assays
WO2001055708A2 (en) * 2000-01-27 2001-08-02 Abbott Laboratories Method of processing a sample containing at least one biological element
WO2001055708A3 (en) * 2000-01-27 2002-05-02 Abbott Lab Method of processing a sample containing at least one biological element
JP2003530087A (en) * 2000-01-27 2003-10-14 アボット・ラボラトリーズ Method of processing a sample containing at least one biological component
US9862984B2 (en) 2006-04-21 2018-01-09 Nanobiosym, Inc. Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
US11807892B2 (en) 2006-04-21 2023-11-07 Nanobiosym, Inc. Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
US8101032B1 (en) 2007-05-18 2012-01-24 University Of Central Florida Research Foundation, Inc. Ethanol based gel fuel for a hybrid rocket engine
EP2766945A1 (en) * 2011-10-12 2014-08-20 Areva Electrode for electrochemical cell and method of manufacturing such an electrode
US10933417B2 (en) 2013-03-15 2021-03-02 Nanobiosym, Inc. Systems and methods for mobile device analysis of nucleic acids and proteins

Also Published As

Publication number Publication date
GB9613980D0 (en) 1996-09-04

Similar Documents

Publication Publication Date Title
US6033850A (en) Electrochemical denaturation of double-stranded nucleic acid
EP0973885B1 (en) Disassociation of interacting molecules
EP0846161B1 (en) Release of intracellular material
EP0636185B1 (en) Electrochemical treatment of nucleic acid containing solutions
US20020119480A1 (en) Purification devices comprising immobilized capture probes and uses therefor
WO1992004470A1 (en) Electrochemical denaturation of double-stranded nucleic acid
WO1998000562A1 (en) Denaturation of double-stranded nucleic acid
US6335161B1 (en) Release of intracellular material and the production therefrom of single stranded nucleic acid
US6794130B2 (en) Electrode capture of nucleic acid
WO1998002573A1 (en) Denaturation of double-stranded nucleic acid
US10280392B2 (en) Methods and devices for non-thermal polymerase chain reaction
JP3383360B2 (en) DNA analysis method
AU3330800A (en) Method of synthesizing nucleic acids

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP KR SG US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 98503927

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase